Rxo (RXO) Short-Term Debt issuances (2023 - 2025)
Historic Short-Term Debt issuances for Rxo (RXO) over the last 3 years, with Q4 2025 value amounting to $95.0 million.
- Rxo's Short-Term Debt issuances rose 17142.86% to $95.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $566.0 million, marking a year-over-year increase of 13781.51%. This contributed to the annual value of $566.0 million for FY2025, which is 13781.51% up from last year.
- As of Q4 2025, Rxo's Short-Term Debt issuances stood at $95.0 million, which was up 17142.86% from $210.0 million recorded in Q3 2025.
- In the past 5 years, Rxo's Short-Term Debt issuances registered a high of $300.0 million during Q1 2025, and its lowest value of -$39.0 million during Q2 2025.
- Its 3-year average for Short-Term Debt issuances is $97.8 million, with a median of $80.0 million in 2024.
- Examining YoY changes over the last 5 years, Rxo's Short-Term Debt issuances showed a top increase of 66923.08% in 2025 and a maximum decrease of 14875.0% in 2025.
- Over the past 3 years, Rxo's Short-Term Debt issuances (Quarter) stood at $76.0 million in 2023, then tumbled by 53.95% to $35.0 million in 2024, then soared by 171.43% to $95.0 million in 2025.
- Its Short-Term Debt issuances was $95.0 million in Q4 2025, compared to $210.0 million in Q3 2025 and -$39.0 million in Q2 2025.